Walckiers D, Van der Veken J, Papoz L, Stroobant A
Institut d'Hygiène et d'Epidémiologie, Section d'Epidémiologie, Brussels, Belgium.
Eur J Clin Pharmacol. 1992;43(6):613-9. doi: 10.1007/BF02284959.
Within the framework of a European concerted action on diabetes mellitus (EURODIAB SubArea C), an epidemiological study was established in Belgium in 1990 in order to estimate the prevalence of drug-treated diabetes mellitus. An assessment was made of the sales of insulin and oral antidiabetic drugs and the average daily dose used. A sample of people with diabetes, clients of 107 pharmacies, provided the data to establish average daily doses. Those pharmacies, spread over the 9 provinces of the country, represent 2% of all private pharmacies in Belgium. Over a 2 month period each pharmacist presented a questionnaire to each client receiving an antidiabetic drug. In 1990, 164 per 10,000 inhabitants were treated with antidiabetic drugs, which means that there were approximately 163,000 drug-treated diabetics in Belgium. At the time of the survey 65% of the diabetics in the sample were 60 years or older. Overall, 38% of drug-treated diabetics took insulin, and 30% of them took only human insulin. Treatment type varied by the province where the pharmacy was located. The provinces of Hainaut and Luxembourg-Namur had a higher percentage of diabetics on oral treatment. This is the first description in Belgium of the prevalence of drug-treated diabetes and of the pattern of prescribing of these drugs.
在欧洲糖尿病协同行动（EURODIAB子区域C）的框架内，1990年在比利时开展了一项流行病学研究，以估算药物治疗糖尿病的患病率。对胰岛素和口服降糖药的销售额以及使用的平均日剂量进行了评估。一个糖尿病患者样本，即107家药店的顾客，提供了用于确定平均日剂量的数据。这些药店分布在该国的9个省份，占比利时所有私人药店的2%。在为期2个月的时间里，每位药剂师向每位正在接受降糖药治疗的顾客发放一份问卷。1990年，每10000名居民中有164人接受降糖药治疗，这意味着比利时约有163000名接受药物治疗的糖尿病患者。在调查时，样本中65%的糖尿病患者年龄在60岁及以上。总体而言，38%的接受药物治疗的糖尿病患者使用胰岛素，其中30%仅使用人胰岛素。治疗类型因药店所在省份而异。埃诺省和卢森堡-那慕尔省接受口服治疗的糖尿病患者比例较高。这是比利时首次对药物治疗糖尿病的患病率及这些药物的处方模式进行描述。
